Key result
Robotic mitral valve repair yields similar 5-year freedom from reoperation vs nonrobotic minimally invasive repair.
Why the study?
Data comparing the outcomes of robotic mitral valve repair versus nonrobotic minimally invasive mitral valve repair were lacking.
Does robotic mitral valve repair improve short- and mid-term outcomes compared to nonrobotic minimally invasive mitral valve repair?
Cohort (n=138)
No
Does robotic mitral valve repair improve short- and mid-term outcomes compared to nonrobotic minimally invasive mitral valve repair?
Absolute Event Rate: 97.1% vs 95.7%
p-value: p=0.63
Robotic and nonrobotic minimally invasive mitral valve repair offer comparable mid-term clinical and echocardiographic outcomes, with a slightly shorter hospital stay for the robotic approach.
Comparable short- and mid-term outcomes support either robotic or nonrobotic MVr in experienced centers; leaves open durability, cost, and broader applicability.
BACKGROUND: Minimally invasive mitral valve repair (MVr) is commonly performed. Data on the outcomes of robotic MVr versus nonrobotic minimally invasive MVr are lacking. We sought to compare the short-term and mid-term outcomes of robotic and nonrobotic MVr. METHODS: We reviewed all patients who underwent robotic MVr (n = 424) or nonrobotic MVr via right mini-thoracotomy (n = 86) at Mayo Clinic, Rochester, MN, from January 2015 to February 2020. Data on baseline and operative characteristics, operative and long-term outcomes were analyzed. Patients were matched 1:1 using propensity scores. RESULTS: Sixty-nine matched pairs were included in the study. The median age was 59 years (interquartile range [IQR]: 54-69) and 75% (n = 103) were male. Baseline characteristics were similar after matching. Robotic and nonrobotic MVr had similar operative characteristics, except that robotic had longer cross-clamp times (57 [48-67] vs. 47 [37-58] min, p < .001) and more P2 resections (83% vs. 68%, p = .05) compared to nonrobotic MVr. There was no difference in operative outcomes between groups. Hospital stay was shorter after robotic MVr (4 [3-4] vs. 4 [4-6] days, p = .003). After a median follow-up of 3.3 years (IQR, 2.1-4.5), there was no mortality in either group, and there was no difference in freedom from mitral valve reoperations between robotic and nonrobotic MVr (5 years: 97.1% vs. 95.7%, p = .63). Follow-up echocardiogram analysis predicted excellent freedom from recurrent moderate-or-severe mitral regurgitation at 3 years after robotic and nonrobotic MVr (90% vs. 92%, p = .18, respectively). CONCLUSIONS: Both short-term and mid-term outcomes of robotic and nonrobotic minimally invasive mitral repair surgery are comparable.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2022) conducted a cohort in Mitral valve disease requiring repair (n=138). Robotic mitral valve repair vs. Nonrobotic minimally invasive mitral valve repair via right mini-thoracotomy was evaluated on Freedom from mitral valve reoperations at 5 years (p=0.63). Robotic mitral valve repair resulted in similar 5-year freedom from mitral valve reoperations compared to nonrobotic minimally invasive repair (97.1% vs. 95.7%, p=0.63).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: